Work

Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models

Year: 2021

Type: article

Source: Cancer Letters

DOI: 10.1016/j.canlet.2020.12.038

Authors: Christina A. Wicker, Brian G. Hunt, Sunil Krishnan, Kathryn Aziz, Shobha Parajuli, Sarah Palackdharry, William R. Elaban, Trisha M. Wise-Draper, Gordon B. Mills, Susan E. Waltz, Vinita Takiar

Institutions: University of Cincinnati, Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida), The University of Texas MD Anderson Cancer Center, Oregon Health & Science University, Cincinnati VA Medical Center

Language: English

Topic: Cancer, Hypoxia, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Veterans Affairs, College of Medicine, University of Cincinnati, National Cancer Institute

Awards: G3941954995, Targeting glycolytic metabolism in RON-driven breast cancer, G5173757561, G5411901319, G7303595192

OpenAlex ID: W3120598121

FWCI: 4.609

Cites: 42

Cited by: 99

Related to: 10